Dobutamine vs levosimendan in patients with low cardiac output following cardiac surgery

Trial Profile

Dobutamine vs levosimendan in patients with low cardiac output following cardiac surgery

Completed
Phase of Trial: Phase II

Latest Information Update: 11 Jan 2014

At a glance

  • Drugs Dobutamine (Primary) ; Levosimendan (Primary)
  • Indications Liver dysfunction; Low cardiac output
  • Focus Pharmacodynamics
  • Most Recent Events

    • 11 Jan 2014 New trial record
    • 01 Nov 2013 Substudy results published in Anaesthesia and Intensive Care.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top